Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing interferon alfa-2a (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
interferon alfa |
Inferred relationship |
Some |
|
Product containing interferon alfa-2b (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
interferon alfa |
Inferred relationship |
Some |
|
interferon alfa-2b 10 MIE pulver og solvens til injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
interferon alfa |
Inferred relationship |
Some |
|
interferon alfa-2b 5 MIE pulver og solvens til injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
interferon alfa |
Inferred relationship |
Some |
|
interferon alfa-2b 3 MIE pulver og solvens til injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
interferon alfa |
Inferred relationship |
Some |
|
interferon alfa-2b 1 MIE pulver og solvens til injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
interferon alfa |
Inferred relationship |
Some |
|
interferon alfa-2b 6 MIE/ml injektionsvæske, opløsning, hætteglas a 3 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
interferon alfa |
Inferred relationship |
Some |
|
interferon alfa-2a 18 MIE/ml injektionsvæske, opløsning, hætteglas a 1 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
interferon alfa |
Inferred relationship |
Some |
|
interferon alfa-2a 6 MIE/ml injektionsvæske, opløsning i fyldt injektionssprøjte a 0,5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
interferon alfa |
Inferred relationship |
Some |
|
interferon alfa-2a 9 MIE/ml injektionsvæske, opløsning i fyldt injektionssprøjte a 0,5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
interferon alfa |
Inferred relationship |
Some |
|
interferon alfa-2a 12 MIE/ml injektionsvæske, opløsning i fyldt injektionssprøjte a 0,5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
interferon alfa |
Inferred relationship |
Some |
|
interferon alfa-2a 18 MIE/ml injektionsvæske, opløsning i fyldt injektionssprøjte a 0,5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
interferon alfa |
Inferred relationship |
Some |
|
interferon alfa-2b 15 MIE/1 ml fyldt pen |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
interferon alfa |
Inferred relationship |
Some |
|
interferon alfa-2b 25 MIE/1 ml fyldt pen |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
interferon alfa |
Inferred relationship |
Some |
|
interferon alfa-2b 50 MIE/1 ml fyldt pen |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
interferon alfa |
Inferred relationship |
Some |
|
interferon alfa-2b 10 MIE/ml injektionsvæske, opløsning, hætteglas a 2,5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
interferon alfa |
Inferred relationship |
Some |
|
interferon alfa-2a 18 MIE/0,6 ml injektionsvæske, opløsning, cylinderampul |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
interferon alfa |
Inferred relationship |
Some |
|
peginterferon alfa-2b 50 µg pulver og solvens til injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
interferon alfa |
Inferred relationship |
Some |
|
peginterferon alfa-2b 80 µg pulver og solvens til injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
interferon alfa |
Inferred relationship |
Some |
|
peginterferon alfa-2b 100 µg pulver og solvens til injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
interferon alfa |
Inferred relationship |
Some |
|
peginterferon alfa-2b 150 µg pulver og solvens til injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
interferon alfa |
Inferred relationship |
Some |
|
peginterferon alfa-2b 120 µg pulver og solvens til injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
interferon alfa |
Inferred relationship |
Some |
|
peginterferon alfa-2a 180 µg/ml injektionsvæske, hætteglas a 1 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
interferon alfa |
Inferred relationship |
Some |
|
Product containing peginterferon alfa-2b (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
interferon alfa |
Inferred relationship |
Some |
|
ribavirin + interferon alfa-2b |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
interferon alfa |
Inferred relationship |
Some |
|
ribavirion 200 mg kapsel + interferon alfa-2b 3 MIE/injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
interferon alfa |
Inferred relationship |
Some |
|
PEG-intron redipen |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
interferon alfa |
Inferred relationship |
Some |
|
PEG-intron redipen 150 µg pulver + 0,5 ml sterilt vand |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
interferon alfa |
Inferred relationship |
Some |
|
PEG-intron redipen 120 µg pulver + 0,5 ml sterilt vand |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
interferon alfa |
Inferred relationship |
Some |
|
PEG-intron redipen 50 µg pulver + 0,5 ml sterilt vand |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
interferon alfa |
Inferred relationship |
Some |
|
PEG-intron redipen 80 µg pulver + 0,5 ml sterilt vand |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
interferon alfa |
Inferred relationship |
Some |
|
interferon alfa-2b 10 MIE/2 ml injektionsvæske, opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
interferon alfa |
Inferred relationship |
Some |
|
peginterferon alfa-2b 150 µg pulver + solvens til injektionsvæske, opløsning, fyldt pen |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
interferon alfa |
Inferred relationship |
Some |
|
peginterferon alfa-2b 50 µg pulver + solvens til injektionsvæske, opløsning, fyldt pen |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
interferon alfa |
Inferred relationship |
Some |
|
peginterferon alfa-2b 80 µg pulver + solvens til injektionsvæske, opløsning, fyldt pen |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
interferon alfa |
Inferred relationship |
Some |
|
peginterferon alfa-2b 100 µg pulver + solvens til injektionsvæske, opløsning, fyldt pen |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
interferon alfa |
Inferred relationship |
Some |
|
peginterferon alfa-2b 120 µg pulver + solvens til injektionsvæske, opløsning, fyldt pen |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
interferon alfa |
Inferred relationship |
Some |
|
peginterferon alfa-2a 180 µg/0,5 ml injektionsvæske, opløsning i fyldt injektionssprøjte |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
interferon alfa |
Inferred relationship |
Some |
|
peginterferon alfa-2a 135 µg/0,5 ml injektionsvæske, opløsning i fyldt injektionssprøjte |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
interferon alfa |
Inferred relationship |
Some |
|
Interferon alfa-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
interferon alfa |
Inferred relationship |
Some |
|
interferon alfa-2a 18 MIE/0,5 ml injektionsvæske, opløsning i fyldt injektionssprøjte |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
interferon alfa |
Inferred relationship |
Some |
|
interferon alfacon 130 µg/ml injektionsvæske, opløsning, cylinderampul a 0,3 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
interferon alfa |
Inferred relationship |
Some |
|
interferon alfa-2b 5 MIE/pulver, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
interferon alfa |
Inferred relationship |
Some |
|
interferon alfa-2b 25 MIE/pulver, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
interferon alfa |
Inferred relationship |
Some |
|
interferon alfa-2b 50 MIE/pulver, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
interferon alfa |
Inferred relationship |
Some |
|
interferon alfa-2b 10 MIE/hætteglas pulver |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
interferon alfa |
Inferred relationship |
Some |
|
interferon alfa-2b 3 MIE/pulver, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
interferon alfa |
Inferred relationship |
Some |
|
interferon alfa-2b 18 MIE/pulver, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
interferon alfa |
Inferred relationship |
Some |
|
interferon alfa-2b 25 MIE/opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
interferon alfa |
Inferred relationship |
Some |
|
interferon alfa-2b 18 MIE/opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
interferon alfa |
Inferred relationship |
Some |
|
interferon alfa-2b 3 MIE/opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
interferon alfa |
Inferred relationship |
Some |
|
interferon alfa-2b 5 MIE/opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
interferon alfa |
Inferred relationship |
Some |
|
interferon alfa-2b 30 MIE opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
interferon alfa |
Inferred relationship |
Some |
|
interferon alfa-2b 60 MIE/IE opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
interferon alfa |
Inferred relationship |
Some |
|
interferon alfa-2b 150 µg pulver |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
interferon alfa |
Inferred relationship |
Some |
|
interferon alfa-2b 300 µg pulver |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
interferon alfa |
Inferred relationship |
Some |
|
interferon alfa-2b 120 µg pulver |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
interferon alfa |
Inferred relationship |
Some |
|
interferon alfa-2b 600 µg pulver |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
interferon alfa |
Inferred relationship |
Some |
|
interferon alfa-2b 100000 µg pulver |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
interferon alfa |
Inferred relationship |
Some |
|
interferon alfa-2b 50 µg pulver |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
interferon alfa |
Inferred relationship |
Some |
|
Product containing peginterferon alfa-2a (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
interferon alfa |
Inferred relationship |
Some |
|
interferon alfa-n3 humant leu 5 MIE/ml injektionsvæske, opløsning, hætteglas a 1 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
interferon alfa |
Inferred relationship |
Some |
|
interferon alfa-2a 6 MIE/injektionsvæske, opløsning, hætteglas a 1 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
interferon alfa |
Inferred relationship |
Some |
|
interferon alfa-2a 9 MIE/injektionsvæske, opløsning, hætteglas a 0,9 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
interferon alfa |
Inferred relationship |
Some |
|
interferon alfa-2a 36 MIE/ml injektionsvæske, opløsning, hætteglas a 1 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
interferon alfa |
Inferred relationship |
Some |
|
interferon alfa-2a 3 MIE/injektionsvæske, opløsning, hætteglas a 1 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
interferon alfa |
Inferred relationship |
Some |
|
interferon alfa-2a 18 MIE/3 ml injektionsvæske, opløsning, hætteglas a 3 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
interferon alfa |
Inferred relationship |
Some |
|
interferon alfa-2a 3 MIE/injektionsvæske, opløsning, fyldt sprøjte a 0,5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
interferon alfa |
Inferred relationship |
Some |
|
Interferon alfa-2a 6miu/vial injection solution 0.5mL syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
interferon alfa |
Inferred relationship |
Some |
|
Interferon alfa-n1 (substance) |
Is a |
False |
interferon alfa |
Inferred relationship |
Some |
|
Interferon alfa-2a |
Is a |
False |
interferon alfa |
Inferred relationship |
Some |
|
Interferon alfa-2b |
Is a |
False |
interferon alfa |
Inferred relationship |
Some |
|